Patent · US Active

Optimized polypeptide for a subunit vaccine against avian reovirus

US11541111B2 · kind B2 · utility

0Cited by
1References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 5, 2017
Grant dateJan 3, 2023
Priority date
Expiry dateJan 5, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2720/12034
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An isolated polypeptide comprising an amino acid sequence corresponding to the amino acid residues forming a full or partial α-helical domain, the hinge domain, the β-triple spiral domain and a full or partial globular head domain of an avian reovirus sigma C protein, and lacking the amino acid sequence that is N-terminal to said α-helical domain is provided. Furthermore, a vaccine comprising, or a viral vector expressing, at least one of the isolated polypeptides of the present invention is provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.